Abstract:
The present invention provides an optically active compound of general formula (I) and salts thereof: wherein R' is selected from a group consisting of t-butyl amine, n-butylamine, iso- butylamine, iso-propyl amine, 4-phenyl-piperazine-1-ylamine, 4-(2-methoxyphenyl)- piperazin-1-ylamine, and 3, 4-dimethoxy phenethyl amine; wherein R1, R2 and R3 are selected from the group consisting of hydrogen, methyl or iso pentenyl; R4, R5 and R6 are selected from the group consisting of OH, O-alkyl, O-benzyl, O-substituted phenyl or combination thereof.
Abstract:
The present invention discloses a bioactive fraction obtained from Xylocarpus useful for the treatment of diabetes and dyslipidemia. Further, it relates to a pharmaceutical composition useful as antidiabetic and antidyslipidemic agent. The current embodiment also discusses to a method of treating diabetes and dyslipidemia in a subject. Further, the present invention relates to the novel isomeric xyloccensins and use thereof.
Abstract:
The present invention discloses a bioactive fraction obtained from Xylocarpus useful for the treatment of diabetes and dyslipidemia. Further, it relates to a pharmaceutical composition useful as antidiabetic and antidyslipidemic agent. The current embodiment also discusses to a method of treating diabetes and dyslipidemia in a subject. Further, the present invention relates to the novel isomeric xyloccensins and use thereof.
Abstract:
The present invention provides an optically active compound of general formula (I) and salts thereof: wherein R' is selected from a group consisting of t-butyl amine, n-butylamine, iso- butylamine, iso-propyl amine, 4-phenyl-piperazine-1-ylamine, 4-(2-methoxyphenyl)- piperazin-1-ylamine, and 3, 4-dimethoxy phenethyl amine; wherein R 1 , R 2 and R 3 are selected from the group consisting of hydrogen, methyl or iso pentenyl; R 4 , R 5 and R 6 are selected from the group consisting of OH, O-alkyl, O-benzyl, O-substituted phenyl or combination thereof.
Abstract:
The present invention provides novel substituted flavone derivatives which exhibit anti hyperglycemic and antidyslipedemic activity. The invention also provides a method for controlling type ii diabetes and associated hyperlipidemic conditions in a mammal by administering compound of the present invention and compositions containing these derivatives.